LEMAITRE VASCULAR INC — Form 8-K
Filed October 15, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
On October 9, 2026, LeMaitre Vascular Inc. (market cap ~$1.7B) filed an 8-K disclosing Item 5.02 regarding departure of directors or officers and compensatory arrangements of certain officers. The specific names, amounts, dates, and nature of the compensation changes are not provided in the accessible header text of this filing.
Why this rating
Officer compensation arrangement disclosures are routine 8-K filings absent specific material changes. Without concrete details on departures, dollar amounts, or equity grants, cannot assess materiality relative to company size.
Extracted items
See more from October 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.